Cupid Limited (BOM: 530843)

Market Cap	22.56B
Revenue (ttm)	1.84B
Net Income (ttm)	508.75M
Shares Out	268.47M
EPS (ttm)	1.90
PE Ratio	44.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,237
Open	84.01
Previous Close	84.01
Day's Range	82.09 - 85.00
52-Week Range	40.34 - 141.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Cupid

Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM Antibody, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy hCG detection, LH ovulation rapid, and dengue NS1 test; and deodorant and pocket perfumes. It also exports its products to countries in Afric...

• Industry: Fabricated Rubber Products, Not Elsewhere Classified
• Founded: 1993
• Employees: 169
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530843

Financial Performance

In 2023, Cupid's revenue was 1.71 billion, an increase of 7.38% compared to the previous year's 1.59 billion. Earnings were 398.55 million, an increase of 26.19%.